News from us and our partners
Tags
Topics
0 results
Elicit Plant makes C&EN’s list of '10 Start-Ups to Watch'
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
Myricx Bio appoints Dr Chris Martin, biotech entrepreneur and ADC pioneer, as Chairman of its Board of Directors
Sofinnova Partners enhances leadership in Medtech acceleration with key appointments
AAVantgarde appoints Dr. Peter K. Kaiser to the Board of Directors
Recor Medical and Otsuka Medical Devices announce first FDA-approved Renal Denervation System for the treatment of hypertension
Gender diversity in Venture Capital: “Visible and invisible barriers” slow progress
LimFlow announces agreement to be acquired by Inari Medical
Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases
Inari Medical expands Its patient-focused mission with agreement to acquire LimFlow
AAVantgarde appoints Michael Heffernan as Chairman of its Board of Directors
Betteromics raises $20 million in Series A financing, led by Sofinnova Partners and Triatomic Capital
L’école AI, creator of “machine teaching” technology, raises 3 million USD in Seed funding from Sofinnova Partners
Sofinnova Partners raises $200M Digital Medicine Fund
EnginZyme produces key mRNA vaccine ingredient using biocatalysis